1 United States Renal Data System. Patient mortality and survival. Am J Kidney Dis 1997; 30: 86-106
2 Brown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP. Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994;9:1136-1142
3 Raine AEG, Margreiter R, Brunner FP et al. Report on management of renal failure in Europe, XXII. Nephrol Dial Transplant 1992; 7 (Suppl. 2): 7-35
4Leschke M. et al. Koronare Herzkrankheit bei Patienten mit terminaler Niereninsuffizienz. Dtsch. Med. Wschr. 1997;122:976-982
5 Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998;339:799-805
6 Braun WE, Phillips D, Vidt DG et al. Coronary arteriography and coronary artery disease in 99 diabetic and nondiabetic patients on chronic hemodialysis or renal transplantation programs. Transplant Proc 1981; 13: 128-135
7Sean W. Murphy, Patrick S. Parfrey. Screening for cardiovascular disease in dialysis patients. Current Opinion in Nephrology and Hypertension. 1996;5:532-540
8 Goodman WG, Goldin J, Kuizon BD et al. Coronary-Artery Calcification In Young Adults With End-Stage Renal Disease Who Are Undergoing Dialysis. N Engl J Med 2000;342:1478-1483
9 Charles A. et al. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998;339:799-805
10 Griendling KK, Murphy TJ, Alexander RW. Molecular biology of the renin-angiotensin system. Circulation 1993; 87: 1816-1828
11 Paul M. Das Renin-Angiotensin-System als Grundlage für Hypertonie und koronare Herzkrankheit – Rolle genetischer Faktoren. Z Kardiol. 2000;89:264-268.
12 Jeunemaitre X, Soubrier F, Kotelevstev Y, Lifton R, Williaams C, Charru A, Hunt S, Hopkins S, Williams R, Laouel J, Corvol P. Molecular basis of human hypertension:
The role of angiotensinogen. Cell 1992; 71: 169-180
13 Danser Jan A.H. et al. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels. J-hypertens.1998 Dec; 16(12 Pt 2) :1879-83.
14 Corvol P. et al. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension. Pathol Biol Paris 1997;45:229-239.
15 Barley J. et al. Angitensinogen Met235-Thr Polymorphism in a London normotensive and hypertensive black and white Population. J Hum Hypertens.
1994;8:639-640.
16 Katsuya T, Koike G, Yee T, Sharpe N, Jaskson R, Norton R, Horiuchi M, Pratt R, Dzau V, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345: 1600-1603
17 Ishigami T, Umemura S, Iwamoto T, Tamura K, Hibi K, Yamaguchi S, Nyui N, Kimura K, Miyazaki N, Ishii M. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 1995; 91: 951-954.
18 Winkelmann BR, Russ AP, Nauck M, Klein B, Bohm BO, Maier V, Zoth R, Matheis G, Wolf A, Wieland H, Groß W, Galton D. Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. Am Heart J 1999; 137: 698-705.
19 Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S, Nakata Y, Higashino Y, Fujii K, Mikami H, Miki T, Ogihara T. Enhanced predictability of myokardial infarction in Japanese by combined genotype analysis. Hypertension 1995; 25: 950-953.
20 Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:
1343-1346
21 Schunkert H. Polymorphism of the angiotensiogen-converting Enzyme gene and cardiovascular disease. J Mol Med. 1997;75:867-875.
22 Osterop Arthur P.R.M. et al. AT1 receptor A/C1166 Polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension.
1998;32:825-830.
23 Schunkert H. et al. Association between a deletion Polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med.
1994;330:1634-8
24 Markus HS, Barley J, Lunt R, Bland JM, Jeffrey S, Carter ND, Brown MM.
Angiotensin-converting enzyme gene deletion polymorphism: A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995; 26:1329-1333
25 Kario K, Kanai N, Saito K, Nago N, Takefumi M, Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 1996; 93: 1630-1633
26 Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994 ; 24 (1) :63-69
27 van Geel P, Pinto Y, Voors A, Buikema H, Oosterga M, Crijns H, van Gilst W.
Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 2000; 35: 717-721
28 Pailard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, Ardaillou R, Soubrier F. Genotype phenotype relationships of the RAS in a normal population.
Hypertension 1999; 34: 423-429
29 Miller JA, Thai K, Scholey JW. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 1999; 56: 2173-2180
30 Fatini C, Abbate R, Pepe G, Battaglini B, Gensin F, Ruggiano G, Gensini GF, Guazzelli R. Searching for a better assessment of the individual coronary risk profile.
The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen polymorphisms. Eur Heart 2000; 21: 633-638
31 Nakauchi Y, Suehiro T, Yamamoto M, Yasuoka N, Ari K, Kumon Y, Hamashige N, Hashimoto K. Significance of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphism as a risk factor for coronary heart disease.
Atherosclerosis 1996 ; 125 : 161-169
32 Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, Soubrier F, Cambien F. Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994; 344(8927): 910-913
33 Alvarez R, Reguero JR, Batalla A, Iglesias-Cubero G, Cortina A, Alvarey V, Coto E. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms:
Association with early coronary disease. Cardiovasc Res 1998; 40: 375-379
34 Gardemann A, Nguyen QD, Humme J, Stricker J, Katz N, Tillmanns H, Hehrlein FW, Rau M, Haberbosch W. Angiotensin II type 1 receptor A1166C gene polymorphism: Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these diseases. Eur Heart J 1998; 19:
1657-1665
35 Brugada R. et al. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Invest Med.
1997;45:542-551.
36 Hamon M, Amant C, Bauters C, Richard J, HelbecqueN, McFadden E, Lablanche J, Bertrand B, Amouyel P. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. Heart 1997; 77: 502-505
37 Castellano M, Muiesan M, Beschi M, Rizzoni D, Cinelli A, Salvetti M, Pasini G, Porteri E, Bettoni G, Zulli R, Agabiti-Rosei E. Angiotensin II type 1 receptor A/C1166 polymorphism: Relationships with blood pressure and cardiovascular structure.
Hypertension 1996; 28: 1076-1080
38 Mattei MG, Hubert C, Alhenc-Gelas F, Roeckel N, Corvol P, Soubrier F.
Angiotensin I converting enzyme gene is on chromosome 17. Cytogenet Cell Genet 1989; 51: 1041
39 Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P.
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 1988; 85. 9386-9390
40 Hubert C, Houot AM, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991; 266: 15377-15383
41 Mullis KB, Fallona FA. Specific synthesis of DNA in vitro via a polymerase catalyzed chain reaction. Methods Enzymol 1987; 155: 335-350
42 Shanmugam V, Sell K, Saha B. Mistyping ACE Heterozygotes. PCR Methods and Applications 1993; 3: 120-121
43 Kageyama R, Ohkubo H, Nakanishi S. Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence. Biochemistry 1984;
23: 3603-3609
44 Isa MN, Boyd E, Morrison N, Harrap S, Clauser E, Connor JM. Assignment of the human angiotensinogen gene to chromosome band 1q42-43 by non-isotopic in situ hybridization. Genomics 1990; 8: 598-600
45 Gailard I, Mattei MG, Clauser E, Corvol P. Structure of Human Angiotensinogen Gene. DNA 1989; 8: 87-99
46 Chiu T, Herblin W, Mc Call D, Ardecky R, Carini D, Duncia J, Pease L, Wong P, Wexler R, Johnson A, Timmermanns P. Identification of angiotensin II receptor subtypes. Bioch Biophys Res Commun 1989; 165: 196-203
47 Curnow KM, Pascoe L, White PC. Genetic analysis of the human type-1 angiotensin II receptor. Mol Endocrinol 1992; 6: 113-118
48 Szpirer C, Riviere M, Szpirer J, Levan G, Guo DF, Iwai N, Inagami T.
Chromosomal assignement of human and rat hypertension candidate genes: type 1 angiotensin II receptor genes and A5 gene. J Hypertens 1993; 11: 919-925
49 Kim S, Iwao H. Molekular and cellular mechanisms of Angiotensin II-mediated cardiovascular and renal diseases. Pharmacological Reviews 2001; 52: 11-34
50 Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359(6396):588-9
51 Staessen JA, Wang JG, Ginocchio G, Petrov V, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15:1579-1592
52 Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P.
Insertion/deletion polymorphism of the angiotensin-converting gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus.
Proc Natl Acad Sci USA 1994; 91: 3662-3665
53 Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Boelskifte S, Borch-Johansen K. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995; 38(7): 798-803
54 Losito A, Kalidas K, Santoni S, Ceccarelli L, Jeffery S. Polymorphism of renin-angiotensin system genes in dialysis patients – association with cerebrovascular disease. Nephrol Dial Transplant 2002; 17:2184 - 2188
55 Wang AY, Chan JC, Wang M, Poon E, Lui SF, Li PK, Sanderson J. Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients. Kidney Int 2003; 63(5): 1899 - 907
56 Aucella F, Margaglione M, Vigilante M, Gatta G, Grandone E, Forcella M, Ktena M, Min A, Salatino G, Procaccini D, Stallone C. PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis. Nephrol Dial Transplant 2003; 18: 1142 - 1146
57 Jeunemaitre X, Ledru F, Battaglia S, Guillanneuf MT, Courbon D, Dumont C, Darmon O, Guize L, Guermonprez JL, Diebold B, Ducimetiere P. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: The CORGENE study. Hum Genet. 1997; 99(1): 66-73
58 Berge KE, Bakken A, Bohn M, Erikssen J, Berg K. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet.
1997; 52(2): 71-6
59 Winkelmann BR, Nauck M, Klein B, Russ AP, Bohm BO, Siekmeier R, Ihnken K, Verho M, Gross W, Marz W. Deletion polymorphism of the agiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med. 1996;125(1):19-25
60 Eichner JE, Christiansen VJ, Moore WE, Dunn ST, Schechter E. Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients.
Atherosclerosis 2001; 154(3): 673-9
61 Pfohl M, Koch M, Prescod S, Haase KK, Haring HU, Karsch KR. Angiotensin I-converting enzyme gene polymorpohism, coronary artery disease and myocardial infarction. An angiographycally controlled study. Eur Heart J. 1999; 20(18): 1318-25
62 Rodriguez-Perez JC, Rodriguez-Esparragon F, Hernandez-Perera O, Anabitarte A, Losada A, Medina A, Hernandez E, Fiuza D, Avalos O, Yunis C, Ferrario CM.
Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene. J Am Coll Cardiol. 2001; 37(6):
1536-42
63 Olivieri O, Grazioli S, Pizzolo F, Stranieri C, Trabetti E, Beltrame F, Girelli D, Pignatti PF, Corrocher R. Different impact of deletion polymorphism of gene on the risk of renal and coronary artery disease. J Hypertens. 2002; 20(1):37-43
64 Arca M, Pannitteri G, Campagna F, Candeloro A, Montali A, Cantini R, Seccareccia F, Campa PP, Marino B, Ricci G. Angiotensin-converting enzyme gene polymorphism is not associated with coronary atherosclerosis and myocardial infarction in a sample of Italian patients. Eur J Clin Invest. 1998; 28(6): 485-90
65 Ferrieres J, Ruidavets JB, Fauvel J, Perret B, Taraszkiewicz D, Fourcade J, Nieto M, Chap H, Puel J. Angiotensin I-converting enzyme gene polymorphism in a low-risk European population for coronary artery disease. Atherosclerosis 1999; 142(1): 211-6
66 Nair KG, Shalia KK, Ashavaid TF, Dalal JJ. Coronary heart disease, hypertension and angiotensinogen gene variants in Indian population. J Clin Lab Anal 2003; 17(5):
141-6
67 Bautista LE, Ardila ME, Gamarra G, Vargas CI, Arenas IA. Angiotensin-converting enzyme gene polymorphism and risk of myocardial infarction in Colombia. Med Sci Monit 2004; 10(8): CR 473-9
68 Petrovic D, Bregar D, Guzic-Salobir B, Skof E, Span M, Terzic R, Petrovic MG, Keber I, Letonja M, Zorc M, Podbregar M, Peterlin B. Sex difference in the effect of ACE-DD genotype on the risk of premature myocardial infarction. Angiology 2004;
55(2): 155-8
69 Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, O´Rourke DF, Cambien F. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med 1994; 87(4): 211-4
70 Sobstyl J, Dzida G, Puzniak A, Mosiewicz J, Hanzlik J. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Polish patients with myocardial infarction. Ann Univ Mariae Curie Sklodowska 2002; 57(2): 21-8
71 Fernandez-Arcas N, Dieguez-Lucena JL, Munoz-Moran E, Ruiz-Galdon M, Espinosa-Caliani S, Aranda-Lara P, Rius-Dias F, Gaitan-Arroyo MJ, De Teresa-Galvan E, Reyes-Engel A. Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction. Clin Genet 2001;
60(1): 50-7
72 Samani NJ, O´Toole L, Martin D, Rai H, Fletcher S, Lodwick D, Thompson JR, Morice AH, Channer K, Woods KL. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. J Am Coll Cardiol 1996; 28(2): 338-44
73 Holmer SR, Bickeboller H, Hengstenberg C, Rohlmann F, Engel S, Lowel H, Mayer B, Erdmann J, Baier C, Klein G, Riegger GA, Schunkert H. Angiotensin converting enzyme gene polymorphism and myocardial infarction a large association and linkage study. Int J Biochem Cell Biol 2003; 35(6): 955-62
74 Canavy I, Henry M, Morange PE, Tiret L, Poirier O, Ebagosti A, Bory M, Juhan-Vague I. Genetic polymorphisms and coronary artery disease in the south of france.
Thromb Haemost 2000; 83(2): 212-6
75 Butler R, Morris AD, Burchell B, Struthers AD. DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans.
Hypertension 1999; 33(5): 1164-8
76 Filippi-Codaccioni E, Denizet A, Fradin S, Grollier G, Morello R, Hamon M. Genetic polymorphism of the angiotensin I converting enzyme and morbi-mortality after myocardial infarction. Arch Mal Coeur Vaiss 2004; 97(1): 15-9
77 Hamon M, Fradin S, Denizet A, Filippi-Codaccioni E, Grollier G, Morello R.
Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutanous coronary intervention. Heart 2003; 89(3): 321-5
78 Tokunaga S, Tsuji H, Nishiue T, Yamada K, Miasaka Y, Saitou D, Iwasaka T.
Lower mortality in patients with the DD genotype of the angiotensin-converting enzyme gene after acute myocardial infarction. Acta Cardiol 2001; 56(6): 351-5
79 Higashiuesato Y, Tana T, Tozawa M, Iseki C, Iseki K, Fukiyama K, Takishita S.
Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and survival in a cohort of chronic hemodialysis patients. Clin Nephrol 2002; 58(5): 370-5
80 Ishimitsu T, Hosoya K, Matsuoka H. The deletion allele of angiotensin-converting enzyme gene polymorphism as a cardiovascular risk factor in patients undergoing long-term hemodialysis. Ann Intern Med 2000 133(11): 924
81 Ishimitsu T, Tsukada K, Ohta S, Inada H, Minami J, Ono H, Matsuoka H. Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism. Am J Kidney Dis 2004; 44(3): 466-75
82 Losito A, Parente B, Cao BG, Jeffrey S, Afzal AR. ACE gene polymorphism and survival in atherosclerotic renovascular disease. Am J Kidney Dis 2000; 35(2): 211-5
83 Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol 2003; 23(7): 1269-75
84 Fomicheva EV, Gukova SP, Larionova-Vasina VI, Kovalev YR Schwartz EI. Gene-gene interaction in the RAS system in the predisposition to myocardial infarction in elder population of St. Petersburg (Russia). Mol Genet Metab 2000; 69(1): 76-80
85 Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R.
M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J hypertens 1999; 17(1): 9-17
86 Jones A, Dhamrait SS, Payne JR, Hawe E, Li P, Toor IS, Luong L, Wootton PT, Miller GJ, Humphries SE, Montgomery HE. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension 2003; 42(4): 500-6
87 Kee F, Morrison C, Poirier O, McCrum E, Mallet C, Nicaud V, McMaster D, Dallongeville J, Fruchart JC, Evans AE. Angiotensin II type-I receptor and ACE polymorphisms and risk of myocardial infarction in men and women. Eur J Clin Invest 2000; 30(12): 1076-82
88 Hindorff LA, Heckbert SR, Tracy R, Tang Z, Psaty BM, Edwards KL, Siscovick DS, Kronmal RA, Nazar-Stewart V. Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events. Am J Hypertens 2002;15(12): 1050-6
89 Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S, Nakata Y, Higashino Y, Fujii K, Mikami H, et al. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995; 25(5): 950-3
90 Alvarez R, Reguero JR, Batalla A, Iglesias-Cubero G, Cortina A, Alvarez V, Coto E. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms:
association with early coronary disease. Cardiovasc Res 1998; 40(2): 375-9
91 Doulton TW, MacGregor GA. Blood Pressure in haemodialysis patients: the importance of the relationship between the renin-angiotensin–aldosteron system, salt intake and extracellular volume. J Renin angiotensin Aldosterone Syst. 2004; 5(1):
14-22
92 Niu T, Chen X, Xu X. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs 2002;
62(7): 977-93
93 Marian AJ, Safavi F, Ferlic L, Dunn JK, Gotto AM, Ballantyne CM. Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin:
the lipoprotein and coronary atherosclerosis study. J Am Coll Cardiol; 2000; 35(1):
89-96
94 Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH.
Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997; 29(5): 1078-82
95 Danser AH, Deinum J, Osterop AP, Admiraal PJ, Schalekamp MA. Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism. J Hypertension 1999; 17 (12 Pt 2): 1867-72
96 Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, Ardaillou R, Soubrier F. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999; 34(3): 423-9
97 Vaughan DE. The renin-angiotensin system and fibrinolysis. Am J Cardiol 1997;
79(5A): 12-6
98 Muller DN, Luft FC. The renin-angiotensin system in the vessel wall. Basic Res Cardiol 1998; 93 Suppl 2: 7-14